BIOCORRX INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.78 USD | +4.00% |
|
+4.00% | 0.00% |
| 03/04 | BioCorRx Inc. Announces Board Resignations | CI |
| 01/04 | BioCorRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 13.91 | 14.58 | 5.151 | 28.98 | 7.474 | 6.754 |
| Enterprise Value (EV) 1 | 17.99 | 12.75 | 5.514 | 30.54 | 9.084 | 8.5 |
| P/E ratio | -2.19 x | -1.6 x | -1.47 x | -5.32 x | -1.61 x | -1.73 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 36.9 x | 60.7 x | 42 x | 600 x | 35 x | 75.7 x |
| EV / Revenue | 47.8 x | 53.1 x | 45 x | 633 x | 42.5 x | 95.3 x |
| EV / EBITDA | -4.12 x | -2.3 x | -0.74 x | -5.76 x | -1.94 x | -2.29 x |
| EV / FCF | 27.9 x | -9.3 x | -1.56 x | -14.8 x | -4.51 x | -9.63 x |
| FCF Yield | 3.59% | -10.8% | -64.1% | -6.74% | -22.2% | -10.4% |
| Price to Book | -2.52 x | -14.7 x | -1.26 x | -4.23 x | -0.93 x | -0.69 x |
| Nbr of stocks (in thousands) | 2,538 | 5,301 | 5,422 | 6,692 | 7,666 | 8,659 |
| Reference price 2 | 5.480 | 2.750 | 0.9500 | 4.330 | 0.9750 | 0.7800 |
| Announcement Date | 16/04/19 | 30/03/20 | 31/03/21 | 31/03/22 | 31/03/23 | 01/04/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.3767 | 0.2403 | 0.1226 | 0.0483 | 0.2138 | 0.0892 |
| EBITDA 1 | -4.369 | -5.532 | -7.415 | -5.304 | -4.671 | -3.713 |
| EBIT 1 | -4.376 | -5.561 | -7.492 | -5.369 | -4.698 | -3.74 |
| Operating Margin | -1,161.81% | -2,314.7% | -6,109.86% | -11,121.62% | -2,196.96% | -4,194.5% |
| Earnings before Tax (EBT) 1 | -6.584 | -6.048 | -3.507 | -5.211 | -4.377 | -3.77 |
| Net income 1 | -6.512 | -6.04 | -3.472 | -5.208 | -4.369 | -3.767 |
| Net margin | -1,728.87% | -2,513.8% | -2,831.68% | -10,789.39% | -2,043.3% | -4,224.89% |
| EPS 2 | -2.507 | -1.714 | -0.6457 | -0.8132 | -0.6070 | -0.4514 |
| Free Cash Flow 1 | 0.6455 | -1.371 | -3.534 | -2.058 | -2.012 | -0.8831 |
| FCF margin | 171.37% | -570.52% | -2,882.07% | -4,263.7% | -941.03% | -990.44% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 16/04/19 | 30/03/20 | 31/03/21 | 31/03/22 | 31/03/23 | 01/04/24 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 4.08 | - | 0.36 | 1.57 | 1.61 | 1.75 |
| Net Cash position 1 | - | 1.83 | - | - | - | - |
| Leverage (Debt/EBITDA) | -0.9346 x | - | -0.049 x | -0.2954 x | -0.3445 x | -0.4704 x |
| Free Cash Flow 1 | 0.65 | -1.37 | -3.53 | -2.06 | -2.01 | -0.88 |
| ROE (net income / shareholders' equity) | 137% | 179% | 133% | 93.3% | 57.7% | 41.5% |
| ROA (Net income/ Total Assets) | -566% | -152% | -163% | -254% | -370% | -405% |
| Assets 1 | 1.151 | 3.963 | 2.136 | 2.054 | 1.18 | 0.9311 |
| Book Value Per Share 2 | -2.180 | -0.1900 | -0.7500 | -1.020 | -1.050 | -1.140 |
| Cash Flow per Share 2 | 0.1100 | 0.5000 | 0.1100 | 0.0100 | 0.0100 | 0.0100 |
| Capex 1 | 0.03 | 0.12 | 0.01 | 0 | - | - |
| Capex / Sales | 8.16% | 51.03% | 7.52% | 4.18% | - | - |
| Announcement Date | 16/04/19 | 30/03/20 | 31/03/21 | 31/03/22 | 31/03/23 | 01/04/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 6.94M | |
| +20.68% | 85.55B | |
| -29.31% | 70.07B | |
| +9.65% | 29.06B | |
| -8.63% | 17.51B | |
| +2.14% | 17.39B | |
| +0.39% | 15.38B | |
| +6.47% | 13.4B | |
| +68.09% | 12.87B | |
| +6.43% | 12.77B |
- Stock Market
- Equities
- BICX Stock
- Financials BioCorRx Inc.